Quantum-Si Honored with Frost & Sullivan’s 2024 Technology Innovation Leadership Award for Next-Generation Protein Sequencing™

QSI 11.13.2024

Full Press ReleaseSEC FilingsOur QSI Tweets

About Gravity Analytica

Recent News

  • 01.22.2025 - Microproteins and the Dark Proteome: Tiny Molecules with Big Potential
  • 01.22.2025 - Quantum-Si’s Innovative Protein Barcoding Enhances Next-Gen Screening for mRNA Therapeutics
  • 01.20.2025 - Quantum-Si Showcases Advances in Multiomics at the Festival of Genomics UK

Recent Filings

    BRANFORD, Conn.--(BUSINESS WIRE)--Nov. 13, 2024--Quantum-Si Incorporated(Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it has been awarded Frost & Sullivan’s prestigious 2024 Technology Innovation Leadership Award inNorth America. This award recognizes QSI’s groundbreaking work in developing the Platinum®instrument, the first benchtop sequencer capable of providing single-molecule resolution at the amino acid level, opening new frontiers for proteomic research.

    Frost & Sullivan’s independent team of experts selected QSI for this honor based on the company’s pioneering technology and commitment to advancing proteomics. The Platinum instrument addresses a crucial need for high-resolution protein sequencing by enabling deep insights into protein structure and function within a compact, accessible, and cost-effective instrument. This technology brings single-molecule protein sequencing into labs of all sizes, transforming the way researchers can explore protein variants, modifications, and interactions without the complex workflows and high costs traditionally associated with protein analysis.

    “Receiving Frost & Sullivan’s 2024 Technology Innovation Leadership Award is a testament to our team’s dedication to advancing the proteomics field,” saidJeff Hawkins, CEO ofQuantum-Si. “The Platinum instrument enables researchers to achieve unprecedented insights at the amino acid level, empowering both core and non-core labs to drive scientific discovery faster and more efficiently.”

    Quantum-Si’s Platinum instrument integrates unique engineering solutions, including proprietary image sensors that enable single-molecule detection and precision sequencing. It captures fluorescence signals from each amino acid binding event, providing an end-to-end solution for direct protein sequencing with high accuracy. The device’s affordability and compact design allow more labs to bring proteomic research in-house, reducing dependence on costly external resources and enhancing productivity.

    Frost & Sullivan’s analysis highlights Quantum-Si’s strong commitment to innovation and operational excellence, recognizing its extensive intellectual property portfolio with over 1,000 issued and pending patents. The award highlights QSI’s strategic approach to advancing technology that addresses the evolving needs of the proteomics field.

    For more information on Quantum-Si’s technology and research applications, please visitThe Protein Sequencing CompanyTM |Quantum-Si

    AboutQuantum-Si Incorporated

    Quantum-Si, The Protein Sequencing CompanyTM, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum®instrument enables Next-Generation Protein SequencingTM that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more atquantum-si.comor follow us onLinkedInorX.

    View source version onbusinesswire.com:https://www.businesswire.com/news/home/20241113522948/en/

    Investor ContactDoug Farrell, VP, Investor Relationsir@quantum-si.comMedia ContactKatherine Atkinson, SVP, Commercial Marketingmedia@quantum-si.com

    Source:Quantum-Si Incorporated

    Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com